J&J awards first grants from AI surgery fund
Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.
Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.
Learning and development has proven key to fighting burnout and ensuring the success of the health system’s people managers, Deborah Yount told HR Dive.
Intellia earlier this year reported a similar grade 4 liver enzyme elevation associated with the gene therapy nexiguran ziclumeran, though analysts at BMO Capital Markets at the time brushed it off as a “non-concern.”
In this deep dive, BioSpace investigates China’s rise as a biotech powerhouse.
Deep Dive: Chinese Biotech Innovation Can’t Be Stopped Read More »
Lynkuet is the first FDA-approved therapy that blocks both the neurokinin 1 and neurokinin 3 receptors to treat hot flashes.
Bayer Gets FDA Nod for Novel Drug to Treat Hot Flashes Read More »
The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.
Corcym, CardioPrecision set sights on robotic heart valve replacement Read More »
The takeover of its competitor, announced Sunday, could also bring some attention to Dyne Therapeutics, which has a similar RNA-based pipeline in rare muscle diseases.
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition Read More »
Unos investigadores han presentado Imprinto, un sistema para incrustar información digital invisible en documentos impresos mediante tinta infrarroja y una cámara especial. Esta tecnología es un ejemplo pionero de una nueva generación de interfaces híbridas entre e …
Crean un sistema para incrustar información digital invisible en documentos impresos Read More »
Se ha comprobado en un estudio reciente que un nuevo biomarcador en sangre permite predecir la progresión de la enfermedad de Alzheimer incluso en sus fases más tempranas, cuando los síntomas todavía no son evidentes. El estudio es obra de un equipo de investigad …
Nuevo biomarcador para predecir la progresión de la enfermedad de Alzheimer Read More »
Unos científicos han desarrollado un nuevo tipo de receptor de radio totalmente óptico basado en las propiedades fundamentales de los átomos de Rydberg. Este nuevo tipo de receptor no solo es extremadamente sensible, sino que también cuenta con calibración interna, …